![](/img/cover-not-exists.png)
Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma
Paul M. Dodd, John A. McCaffrey, Madhu Mazumdar, Evelyn Icasiano, Geralyn Higgins, Harry Herr, Dean F. BajorinVolume:
18
Language:
english
Pages:
5
DOI:
10.1023/a:1006477823378
Date:
August, 2000
File:
PDF, 50 KB
english, 2000